United States· US:49471-001_630c84ab-994f-4686-99bc-deaf6db7cff2
PRE-PEN
A medicinal product containing benzylpenicilloyl polylysine, registered in United States by ALK-ABELLO, INC..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BENZYLPENICILLOYL POLYLYSINE
- Manufacturer
- ALK-ABELLO, INC.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1149471-001-05
- ndc1149471001055 AMPULE in 1 CARTON (49471-001-05) / .25 mL in 1 AMPULE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Benzylpenicilloyl polylysine in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d74bee37-1224-4620-aa6c-5d4b207de550 GET /v1/drugs/d74bee37-1224-4620-aa6c-5d4b207de550?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRADERMAL; SUBCUTANEOUS",
"source": "ndc",
"strength": "60",
"substance": "BENZYLPENICILLOYL POLYLYSINE",
"productndc": "49471-001",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "umol/.25mL",
"application_number": "BLA050114",
"marketing_category": "BLA"
}See everything about benzylpenicilloyl polylysine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.